Research Article

Serum Adipsin Levels in Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome

Volume: 6 Number: 3 December 31, 2024
EN TR

Serum Adipsin Levels in Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome

Abstract

Polycystic ovary syndrome (PCOS) is a chronic and heterogeneous disease associated with obesity, hyperinsulinemia, dyslipidemia and chronic low-grade inflammation. Adipsin is a protein that is mostly secreted from adipose tissue and is a structural homolog of complement factor D, the rate-limiting enzyme of the alternative complement system. The aim of this study was to investigate adipsin levels in adolescents with PCOS and their relationship with obesity. 40 normal weight--children with PCOS and 40 obese-children with PCOS, and 40 normal weight healthy children participated in our study. Adipsin levels of adolescents in each group was measured in morning fasting blood samples by a commercial ELISA kit. Adipsin levels showed statistically significant differences between the groups. (p<0.001). Normal-weight PCOS adolescents had higher adipsin levels than both obese PCOS and healthy controls. A negative correlation was observed between adipsin levels and BMI in the PCOS group (r=-0,457, p<0,001). In conclusion, adipsin can be considered as an independent risk factor in normal weight adolescents with PCOS and may help in the diagnosis of PCOS in normal weight children with other symptoms.

Keywords

Supporting Institution

Gazi University

Project Number

Gazi University Research Fund (Project No: TDK-2023-8311)

Ethical Statement

The study protocol was approved by the Ethical Committe of Gazi University (dated 12.09.2022, ref.no:685)

References

  1. Burgert, T. P. (2024). PCOS and common androgen abnormalities in adolescents. N. K. Tyson, NASPAG Essentials of Pediatric & Adolescent Gynecology (s. 190-204). Elsevier.
  2. Butler, A. E., Moin, A. S. M., Sathyapalan, T., & Atkin, S. L. (2022). Components of the Complement Cascade Differ in Polycystic Ovary Syndrome. International Journal of Molecular Sciences, 23(20), 12232. https://doi.org/10.3390/ijms232012232
  3. Byeon, H. J., Chae, M. K., Ko, J., Lee, E. J., Kikkawa, D. O., Jang, S. Y., & Yoon, J. S. (2023). The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy. Investigative ophthalmology & visual science, 64(11), 13. https://doi.org/10.1167/iovs.64.11.13
  4. Chang, K. J., Chen, J. H., & Chen, K. H. (2024). The Pathophysiological Mechanism and Clinical Treatment of Polycystic Ovary Syndrome: A Molecular and Cellular Review of the Literature. International journal of molecular sciences, 25(16), 9037. https://doi.org/10.3390/ijms25169037
  5. Chedraui, P., Pérez-López, F. R., Escobar, G. S., Palla, G., Montt-Guevara, M., Cecchi, E., Genazzani, A. R., Simoncini, T., & Research Group for the Omega Women's Health Project (2014). Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas, 79(1), 86–90. https://doi.org/10.1016/j.maturitas.2014.06.008
  6. Cook, K. G. (1985). A developmentally regulated mRNA from 3T3 adipocytes encodes a novel serine protease homologue. Proceedings of the National Academy of Sciences of the United States of America, , Oct;82(19):6480-4.
  7. Cook, K. S., Min, H. Y., Johnson, D., Chaplinsky, R. J., Flier, J. S., Hunt, C. R., & Spiegelman, B. M. (1987). Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science (New York, N.Y.), 237(4813), 402–405. https://doi.org/10.1126/science.3299705
  8. Dare, A., & Chen, S. Y. (2024). Adipsin in the pathogenesis of cardiovascular diseases. Vascular pharmacology, 154, 107270. https://doi.org/10.1016/j.vph.2023.107270

Details

Primary Language

English

Subjects

Clinical Sciences (Other)

Journal Section

Research Article

Publication Date

December 31, 2024

Submission Date

December 20, 2024

Acceptance Date

December 25, 2024

Published in Issue

Year 2024 Volume: 6 Number: 3

APA
Emiral, Ç., Buluş, D., Yaşartekin, Y., & Akaydın, S. (2024). Serum Adipsin Levels in Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome. Journal of Gazi University Health Sciences Institute, 6(3), 107-116. https://doi.org/10.59124/guhes.1604306
AMA
1.Emiral Ç, Buluş D, Yaşartekin Y, Akaydın S. Serum Adipsin Levels in Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome. GUHES. 2024;6(3):107-116. doi:10.59124/guhes.1604306
Chicago
Emiral, Çağla, Derya Buluş, Yüksel Yaşartekin, and Sevgi Akaydın. 2024. “Serum Adipsin Levels in Obese and Normal Weight Adolescents With Polycystic Ovary Syndrome”. Journal of Gazi University Health Sciences Institute 6 (3): 107-16. https://doi.org/10.59124/guhes.1604306.
EndNote
Emiral Ç, Buluş D, Yaşartekin Y, Akaydın S (December 1, 2024) Serum Adipsin Levels in Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome. Journal of Gazi University Health Sciences Institute 6 3 107–116.
IEEE
[1]Ç. Emiral, D. Buluş, Y. Yaşartekin, and S. Akaydın, “Serum Adipsin Levels in Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome”, GUHES, vol. 6, no. 3, pp. 107–116, Dec. 2024, doi: 10.59124/guhes.1604306.
ISNAD
Emiral, Çağla - Buluş, Derya - Yaşartekin, Yüksel - Akaydın, Sevgi. “Serum Adipsin Levels in Obese and Normal Weight Adolescents With Polycystic Ovary Syndrome”. Journal of Gazi University Health Sciences Institute 6/3 (December 1, 2024): 107-116. https://doi.org/10.59124/guhes.1604306.
JAMA
1.Emiral Ç, Buluş D, Yaşartekin Y, Akaydın S. Serum Adipsin Levels in Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome. GUHES. 2024;6:107–116.
MLA
Emiral, Çağla, et al. “Serum Adipsin Levels in Obese and Normal Weight Adolescents With Polycystic Ovary Syndrome”. Journal of Gazi University Health Sciences Institute, vol. 6, no. 3, Dec. 2024, pp. 107-16, doi:10.59124/guhes.1604306.
Vancouver
1.Çağla Emiral, Derya Buluş, Yüksel Yaşartekin, Sevgi Akaydın. Serum Adipsin Levels in Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome. GUHES. 2024 Dec. 1;6(3):107-16. doi:10.59124/guhes.1604306

22691                  download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiaW5kaXIucG5nIiwicGF0aCI6ImVjNzgvZGU4Ni9mMjdjLzZhMDRlN2Q4YjYwNmEzLjExNzczOTMwLnBuZyIsImV4cCI6MTc3ODcwOTk5Miwibm9uY2UiOiIzMWQxNTMzOTFkM2IyMTU2NGFiNGI5YjY2ZGQ4MjFlYiJ9.4-PQrEO6baVYBZetYwBgdtJueIQ6XuZO7lFjz-8J31M